| |||||||
| Register | Blogs | FAQ | Members List | Calendar | Science Groups New! | Arcade | Search | Today's Posts | Mark Forums Read |
| Antibody Forum Antibody Forum. Ask and discuss antibody suppliers, antibody related techniques and protocols, and antibody production such as using phage display libraries. |
|
![]() |
| | LinkBack | Thread Tools | Display Modes |
| |||||
| I am working on a project and I am trying to understand what seems to be a simple concept but is confusing me as I read more about it and I figured this group could enlighten my understanding. I understand how mAbs work. However, anti-mAbs are confusing me because I am working on a cancer vaccine project where some studies use immunomodulators in a multicomponent approach to aid vaccine efficacy and others use anti-mAbs as a part of the multicomponent approach. I think that small molecule inhibitors and anti-mAbs do the same thing. For example, small molecule antagonists bind to a receptor decreasing a particular response to the cell. Lets say the result of this antagonist causes attenuation of an immune response. So if I wanted to use anti-mAbs against the same receptor (via attenating lyphocyte signaling) would this be a method to accomplish the same goal as small molecule inhibitors? I'm not sure if I truly understand anti mAbs. I would appreciate any help in this matter. Regards Evans |
| | ||||
| ||||
| |
| |||||
| Quote:
Hope this helps!
__________________ Translational Breast Cancer Research Sylvester Comprehensive Cancer Center University of Miami Miami, FL 33135 tward@med.miami.edu |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads | ||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| anti A1/BFL-1 | simo | Antibody Forum | 1 | 05-21-2008 10:17 AM |